Carcinoembryonic antigen (CEA) measurement during follow-up for rectal carcinoma is useful even if normal levels exist before surgery. A retrospective study of CEA values in the TME trial

European Journal of Surgical Oncology

Volumn 33, Issue 2, 2007, Pages 183-187

  Grossmann, I ^a   de Bock, G H ^a   Meershoek Klein Kranenbarg, W M ^b   van de Velde, C J H ^b   Wiggers, T ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Carcinoembryonic antigen; Colorectal neoplasm; Follow up; Oncology

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECTUM CARCINOMA; RECURRENT CANCER; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; CLINICAL TRIALS; COLECTOMY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NETHERLANDS; PREOPERATIVE CARE; PROGNOSIS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 33847365379     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.10.035     Document Type: Article

References (23)

1. Bruinvels D.J., Stiggelbout A.M., Kievit J., van Houwelingen H.C., Habbema D.F., and van de Velde C.J.H. Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg 219 (1994) 174-182
2. McArdle C. ABC of colorectal cancer: effectiveness of follow-up. BMJ 321 (2000) 1332-1335
3. Meyerhardt J.A., and Mayer R.J. Follow-up strategies after curative resection of colorectal cancer. Semin Oncol 30 (2003) 349-360
4. Kievit J. Follow-up of patients with colorectal cancer: number needed to test and treat. Eur J Cancer 38 (2002) 986-999
5. Longo W.E., and Johnson F.E. The preoperative assessment and postoperative surveillance of patients with colon and rectal cancer. Surg Clin North Am 82 (2002) 1091-1108
6. Kievit J. Colorectal cancer follow-up: a reassessment of empirical evidence on effectiveness. Eur J Surg Oncol 26 (2000) 322-328
7. Desch C.E., Benson III A.B., Somerfield M.R., et al., for the American Society of Clinical Oncology. Colorectal Cancer Surveillance: 2005 update of an American society of clinical oncology practice guideline. J Clin Oncol 23 (2005) 1-8
8. Desch C.E., Benson III A.B., Smith T.J., et al. Recommended colorectal cancer surveillance guidelines by the American society of clinical oncology. J Clin Oncol 17 (1999) 1312-1321
9. National working group gastro-intestinal tumours. Dutch national guidelines on colon cancer: follow-up. Available at http://www.oncoline.nl. Last update 01-06-2005.
10. National Cancer Institute. General information: follow-up. Available at: http://www.cancer.gov/cancertopics/pdq/treatment/colon/healthprofessional#Section_255. Last update 24-04-2006.
11. Grossmann I, G.H. de Bock, C.J.H. van de Velde, J. Kievit, T. Wiggers. Results of a national survey among Dutch surgeons treating patients with colorectal carcinoma. Current opinion about follow-up, treatment of metastasis, and reasons to revise follow-up practice. Colorect Dis, in press.
12. Staab H.J., Anderer F.A., Stumpf E., and Fischer R. Slope analysis of the post-operative CEA time course and it's possible application as an aid in diagnosis of disease progression in gastro-intestinal cancer. Am J Surg 136 (1978) 322-327
13. Wichmann M.W., Lau-Werner U., Müller C., Hornung H.M., Stieber P., and Schildberg F.W. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer. Anticancer Res 20 (2000) 4953-4956
14. Zeng Z., Cohen A.M., and Urmacher C. Usefulness of carcinoembryonic antigen monitoring despite normal preoperative values in node-positive colon cancer patients. Dis Colon Rectum 36 (1993) 1063-1086
15. Yamamoto M., Maehara Y., Sakaguchi Y., et al. Distributions in CEA doubling time differ in patients with recurrent colorectal carcinomas. Hepatogastroenterology 51 (2004) 147-151
16. Kapiteijn E., Marijnen C.A.M., Nagtegaal I.D., et al., for the Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345 (2001) 638-646
17. Peeters K.C., Tollenaar R.A., Marijnen C.A., et al., for the Dutch colorectal Cancer Group. Risk factors for anastomotic failure after total mesorectal excision of rectal cancer. Br J Surg 92 (2005) 211-216
18. Umehara Y., Kimura T., Yoshida M., Oba N., and Harada Y. Comparison of doubling times of serum carcinoembryonic antigen produced by various metastatic lesions in recurrent gastric and colorectal carcinomas. Cancer 71 (1993) 4055-4059
19. Boey J., Cheung H.C., Lai C.K., and Wong J. A prospective evaluation of serum carcinoembryonic antigen (CEA) levels in the management of colorectal carcinoma. World J Surg 8 (1984) 279-286
20. Steele G., Ellenberg S., Ramming K., et al. CEA monitoring among patients in multi-institutional adjuvant G.I. therapy protocols. Ann Surg 196 (1982) 162-169
21. Ng I.O.L., Ho J., Pritchett J., Chan Y.E.T., and Ho F.C.S. CEA tissue staining in colorectal cancer patients-correlation with plasma CEA, histology and staging. Pathology 25 (1993) 219-222
22. Kim Y., Lee S., Jeon H., et al. Gastrointestinal tract cancer screening using fecal carcinoembryonic antigen. Ann Clin Lab Sci 33 (2003) 32-38
23. Fujimoto S., and Kitsukawa Y. Further investigations of immunoreactive carcinoembryonic antigen (CEA) in colorectal cancer patients-with particular emphasis on the correlation between immunoreactive CEA levels in tissue, feces and blood. Jpn J Surg 11 (1981) 27-32